Been a shareholder for a long time and seen lots of ups/downs.
Next FY will be huge in my opinion.
Two key things looking forward which will drive SP growth
- New product Coris approval - initial approval will
have material benefit to SP - wont be long I suspect.
- Increased sales as focus will turn from Covid to infection control (Nan will massively benefit)
Ann: 2022 Half Year Financial Results, page-19
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NAN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$3.73 |
Change
0.000(0.00%) |
Mkt cap ! $1.136B | |||
| Open | High | Low | Value | Volume |
| $3.75 | $3.86 | $3.67 | $5.538M | 1.476M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 69717 | $3.73 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $3.75 | 1094 | 1 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| NAN (ASX) Chart |